Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS
· Real-Time Price · USD
3.27
0.07 (2.19%)
At close: Aug 15, 2025, 3:59 PM
3.28
0.46%
After-hours: Aug 15, 2025, 04:10 PM EDT
Alpha Tau Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 1.07M | n/a | 512K | n/a | 979K | n/a | n/a | 231K | 776K | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -1.07M | n/a | -512K | n/a | -979K | n/a | n/a | -231K | -776K | n/a | n/a | n/a |
Operating Income | -9.31M | -10.27M | -8.29M | -9.05M | -8.42M | -9.94M | -8.93M | -8.17M | -8.64M | -7.99M | -7.36M | -8.01M | -8.78M | -3.94M | -3.63M | -3.48M | -2.73M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.99K | 4.74K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.59M | -9.47M | -6.92M | -7.37M | -7.98M | -7.36M | -4.95M | -8.67M | -8.17M | -3.39M | -2.61M | -1.99M | -25.74M | -3.79M | -4.8M | -6.97M | -11.7M |
Net Income | -8.69M | -9.48M | -6.92M | -7.37M | -7.98M | -7.37M | -4.91M | -8.69M | -8.19M | -3.4M | -2.62M | -2M | -25.74M | -3.78M | -4.8M | -6.98M | -11.71M |
Selling & General & Admin | 2.14M | 2.74M | 2.12M | 2.19M | 1.98M | 2.45M | 2.25M | 2.21M | 2.34M | 2.6M | 2.53M | 2.56M | 3.55M | 714K | 602K | 481K | 546K |
Research & Development | 7.17M | 7.53M | 6.17M | 6.87M | 6.45M | 7.49M | 6.67M | 5.96M | 6.31M | 5.38M | 4.83M | 5.45M | 5.24M | 3.23M | 3.03M | 3M | 2.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.31M | 10.27M | 8.29M | 9.05M | 8.42M | 8.87M | 8.93M | 8.17M | 8.64M | 7.99M | 7.36M | 8.01M | 8.78M | 3.94M | 3.63M | 3.48M | 2.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.97M | 4.74M | 6.02M | n/a | 13.82M | n/a | n/a | n/a |
Selling & Marketing Expenses | 459K | 687K | 529K | 600K | 533K | 452K | 552K | 520K | 400K | 397K | 248K | 121K | 208K | 126K | 102K | 87K | 167K |
Cost & Expenses | 9.31M | 10.27M | 8.29M | 9.05M | 8.42M | 9.94M | 8.93M | 8.17M | 8.64M | 7.99M | 7.36M | 8.01M | 8.78M | 3.94M | 3.63M | 3.48M | 2.73M |
Income Tax Expense | 99K | 2K | n/a | 3K | 1K | 8K | -39K | 26K | 21K | 3K | 9K | 6K | 2K | -14K | -5K | 15K | 11K |
Shares Outstanding (Basic) | 70.45M | 70.09M | 69.9M | 69.87M | 69.71M | 69.67M | 69.47M | 69.32M | 69.21M | 69.11M | 68.8M | 68.43M | 47.5M | 47.5M | 67.62M | 67.62M | 67.62M |
Shares Outstanding (Diluted) | 70.45M | 70.09M | 69.9M | 69.87M | 69.71M | 69.67M | 69.47M | 69.32M | 69.21M | 69.11M | 68.8M | 68.43M | 47.5M | 47.5M | 67.62M | 67.62M | 67.62M |
EPS (Basic) | -0.12 | -0.14 | -0.1 | -0.11 | -0.11 | -0.11 | -0.07 | -0.13 | -0.12 | -0.05 | -0.04 | -0.03 | -0.54 | -0.08 | -0.07 | -0.1 | -0.17 |
EPS (Diluted) | -0.12 | -0.14 | -0.1 | -0.11 | -0.11 | -0.11 | -0.07 | -0.13 | -0.12 | -0.05 | -0.04 | -0.03 | -0.54 | -0.08 | -0.07 | -0.1 | -0.17 |
EBITDA | -9.31M | -5.67M | -8.29M | -8.77M | -8.16M | -8.87M | -8.68M | -8.15M | -8.4M | -2.41M | -7.11M | -7.77M | -8.55M | 685.17K | -3.44M | -3.29M | -2.57M |
EBIT | -9.31M | -5.67M | -8.29M | -9.05M | -8.42M | -9.94M | -8.93M | -8.67M | -8.64M | -7.99M | -7.36M | -8.01M | -8.78M | -3.94M | -3.63M | -3.48M | -2.73M |
Depreciation & Amortization | n/a | n/a | n/a | 280K | 268.5K | 1.07M | 244.75K | 512K | 244.75K | 979K | 244K | 244K | 231K | 776K | 189K | 189K | 164K |